共 29 条
[1]
Cost-Effectiveness of Targeting Patients Undergoing Percutaneous Coronary Intervention for Therapy With Bivalirudin Versus Heparin Monotherapy According to Predicted Risk of Bleeding
[J].
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES,
2010, 3 (04)
:358-U47
[3]
British Cardiovascular Intervention Society, BCIS AUD RET AD INT
[4]
Economic evaluation of bivalirudin with provisional glycoprotein IIb/IIIa inhibition versus heparin with routine glycoprotein IIb/IIIa inhibition for percutaneous coronary intervention - Results from the REPLACE-2 trial
[J].
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY,
2004, 44 (09)
:1792-1800
[6]
The economic burden of complications during percutaneous coronary intervention
[J].
QUALITY & SAFETY IN HEALTH CARE,
2007, 16 (02)
:154-159